This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Medimmune Limited, University of Helsinki. Active years: 2019.
Company Filing History:
1 out of 546 
1 out of 10 
Years Active: 2019
Title: Jane Connor: Innovator in Organ Transplant Protection
Introduction
Jane Connor is a prominent inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of organ transplantation through her innovative research and patented methods. Her work focuses on improving the outcomes of solid organ transplants, particularly in the context of ischemia.
Latest Patents
Jane Connor holds a patent for "Methods of protecting a solid organ transplant tissue with angiopoietin-2 antibodies." This patent outlines methods and uses of antibodies or antigen-binding fragments against Angiopoietin-2 (Ang-2). The disclosure emphasizes the use of anti-Ang2 antibodies for treating ischemia, which is crucial for reducing microvascular permeability, increasing microvascular perfusion, and reducing inflammation in tissues. Additionally, these methods are beneficial for protecting solid organ transplant tissue and preventing chronic tissue transplant rejection.
Career Highlights
Throughout her career, Jane has worked with notable organizations, including Medimmune Limited and the University of Helsinki. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community significantly.
Collaborations
Jane has collaborated with esteemed colleagues such as Kari Alitalo and Simo Syrjala. These partnerships have enriched her research and expanded the impact of her work in the field of organ transplantation.
Conclusion
Jane Connor's innovative approaches to organ transplant protection highlight her dedication to improving medical outcomes for patients. Her patented methods and collaborative efforts continue to influence the field positively.